Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEFFREY THOMAS YORIO

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1215197314
CMS profile
881554
Location
AUSTIN, TX

General Payments · PY2018–2024

$9,647.86

  • Reported across 61 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,120.82

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $16.02 1
PY2019 $234.31 3
PY2020 $1,147.64 3
PY2021 $4,720.56 8
PY2022 $354.46 8
PY2023 $2,054.05 22
PY2024 $1,120.82 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ARRAY BIOPHARMA INC $630.00 05/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131394591 CMS
AstraZeneca Pharmaceuticals LP $29.35 12/23/2024 Food and Beverage Undisputed 01/23/2026 1104244885 CMS
Celgene Corporation $14.05 12/09/2024 Food and Beverage Undisputed 01/23/2026 1101190259 CMS
Daiichi Sankyo Inc. $27.69 11/12/2024 Food and Beverage Undisputed 01/23/2026 1089500838 CMS
Exelixis Inc. $136.78 01/26/2024 Food and Beverage Undisputed 01/23/2026 1138559218 CMS
GENZYME CORPORATION $46.50 05/24/2024 Food and Beverage Undisputed 01/23/2026 1139934853 CMS
Gilead Sciences, Inc. $13.47 03/20/2024 Food and Beverage Undisputed 01/23/2026 1133803548 CMS
Incyte Corporation $84.99 12/20/2024 Education Undisputed 01/23/2026 1141217240 CMS
Iovance Biotherapeutics, Inc. $22.68 08/29/2024 Food and Beverage Undisputed 01/23/2026 1147113856 CMS
Janssen Biotech, Inc. $15.57 05/21/2024 Food and Beverage Undisputed 01/23/2026 1078683688 CMS
Janssen Biotech, Inc. $13.10 09/25/2024 Food and Beverage Undisputed 01/23/2026 1078683779 CMS
Janssen Pharmaceuticals, Inc $22.00 06/04/2024 Education Undisputed 01/23/2026 1078193361 CMS
PFIZER INC. $11.88 04/25/2024 Education Undisputed 01/23/2026 1131397183 CMS
PFIZER INC. $7.98 06/18/2024 Education Undisputed 01/23/2026 1131449213 CMS
Regeneron Healthcare Solutions, Inc. $28.81 03/28/2024 Food and Beverage Undisputed 01/23/2026 1114259634 CMS
Regeneron Healthcare Solutions, Inc. $15.97 08/09/2024 Food and Beverage Undisputed 01/23/2026 1114259636 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.